Powered by

Axios Pro Rata

Jun 05, 2020 - Axios.com
Investments

Everest Medicines , a Chinese drug licensing and commercialization company, raised $310 million in Series C funding from Janchor Partners, RA Capital Management, Hillhouse Capital, and Jiashan SDIC. http://axios.link/LZTP

Athira Pharma (fka M3 Biotech), a Seattle-based regenerative medicine startup focused on neurological diseases, raised $85 million in Series B funding. Perceptive Advisors led, and was joined by RTW Investments, Viking Global Investors, Venrock, Franklin Templeton, Roc...